单位：[1]China Japan Friendship Hosp, Beijing, Peoples R China[2]Ruijin Hosp Luwan, Shanghai, Peoples R China[3]Novonordisk China Pharmaceut Co Ltd, Beijing, Peoples R China[4]Peking Univ, Beijing 100871, Peoples R China
第一作者单位：[1]China Japan Friendship Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Xiao J.,Bian X.,Zhang Y.,et al.COST-EFFECTIVENESS OF SWITCHING TO BIPHASIC INSULIN ASPART FROM HUMAN PREMIX INSULIN IN PEOPLE WITH TYPE 2 DIABETES IN CHINA[J].VALUE in HEALTH.2014,17(3):A250-A250.doi:10.1016/j.jval.2014.03.1460.
APA：
Xiao, J.,Bian, X.,Zhang, Y.&Yang, L..(2014).COST-EFFECTIVENESS OF SWITCHING TO BIPHASIC INSULIN ASPART FROM HUMAN PREMIX INSULIN IN PEOPLE WITH TYPE 2 DIABETES IN CHINA.VALUE in HEALTH,17,(3)
MLA：
Xiao, J.,et al."COST-EFFECTIVENESS OF SWITCHING TO BIPHASIC INSULIN ASPART FROM HUMAN PREMIX INSULIN IN PEOPLE WITH TYPE 2 DIABETES IN CHINA".VALUE in HEALTH 17..3(2014):A250-A250
